Drug Profile
Masitinib companion diagnostic - AB Science/Skuldtech
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator AB Science; Skuldtech
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pancreatic cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Pancreatic-cancer(Diagnosis) in USA
- 03 Nov 2012 Clinical trials in Pancreatic cancer (diagnosis) in USA (unspecified route)